Latest Health stories from Life.
This editorial outlines the current status of GLP-1 coverage in Medicare and Medicaid, highlighting CMS's initiatives aimed at improving access and reducing costs through the BALANCE model.
Discussions at the AACR meeting highlighted the significance of Chinese biotech in cancer research and addressed ongoing communication challenges within the oncology field.
Robert F. Kennedy Jr. is set to testify before the Senate's health care panel today. Viewers can watch the proceedings live as he addresses the committee.
A recent clinical trial in China has shown that gene therapy can lead to significant hearing improvements for individuals with a rare form of deafness, with 90% of participants benefiting.
A recent study indicates that the introduction of the 988 national suicide and crisis hotline has coincided with an 11% reduction in suicide rates among young people in the U.S.
Stay informed with the latest developments in the biotech sector, featuring updates on RevMed, Roche, and Kyverna's CAR-T therapy.
The Trump administration's initiative to provide seniors with affordable obesity medications through Medicare is facing potential financial hurdles for health insurers.
Moderna is advancing its research on a bird flu vaccine, although it has decided to limit its work within the United States. This comes alongside changes in flu shot mandates for U.S. troops.
The rise of MAHA snacks, from protein-infused Pop-Tarts to avocado-oil chips, suggests a shift towards healthier eating. However, nutrition experts caution that the benefits may be overstated.
Thomas Goetz emphasizes that each drug represents a broader narrative involving health, medicine, society, and economics.
As NASA develops plans for human habitation in space, it is crucial to consider the potential risks posed by infectious diseases to interplanetary travelers.
The CDC’s Epidemic Intelligence Service has reached a significant milestone, having trained over 4,300 individuals who are now integral to public health efforts.
Roche is advancing its experimental multiple sclerosis drug to regulators following successful trials, though significant safety concerns persist.
Recent findings from Revolution Medicines highlight promising advancements in KRAS drug development, potentially transforming treatment options for pancreatic cancer patients.
Kyverna Therapeutics is preparing to submit a novel cell therapy for FDA approval, which has shown potential in enhancing mobility for patients with stiff person syndrome during late-stage trials.
Revolution Medicines revealed encouraging findings regarding its KRAS-targeting treatment at the AACR conference, with the NCI director confirming the stability of ongoing cancer research.
In a notable move, key Republican senators are likely to oppose President Trump's proposed cuts to the National Institutes of Health and the reorganization of Health and Human Services for the second consecutive year.
As the leading donor in global health, the U.S. government allocates its budget across several critical program areas, including HIV, tuberculosis, and malaria.
In a recent announcement, Defense Secretary Pete Hegseth stated that the flu vaccine will no longer be mandatory for American military personnel.
In the first quarter, UnitedHealth's financial results surpassed analysts' expectations, particularly in its Optum and UnitedHealthcare divisions, despite facing ongoing hurdles.